Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Enteric Fever Vaccine

NCT04349553 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Enteric Fever

Interventions

BIOLOGICAL: ZH9PA and ZH9
BIOLOGICAL: Placebo
BIOLOGICAL: ZH9PA

Sponsor

Prokarium Ltd

Collaborators

[object Object]